Exoskeleton Market Size, Share, and Trends 2024 to 2034

The global exoskeleton market size was USD 426.02 million in 2023, calculated at USD 496.87 million in 2024 and is expected to be worth around USD 2,313.89 million by 2034. The market is slated to expand at 16.63% CAGR from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 4872
  • Category : ICT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Exoskeleton Market 

5.1. COVID-19 Landscape: Exoskeleton Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Exoskeleton Market, By Mobility

8.1. Exoskeleton Market Revenue and Volume, by Mobility, 2024-2034

8.1.1. Mobile

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Fixed/Stationary

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Exoskeleton Market, By Technology

9.1. Exoskeleton Market Revenue and Volume, by Technology, 2024-2034

9.1.1. Powered

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Non-powered

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Exoskeleton Market, By Extremity 

10.1. Exoskeleton Market Revenue and Volume, by Extremity, 2024-2034

10.1.1. Upper Body

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Lower Body

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Full Body

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Exoskeleton Market, By Structure

11.1. Exoskeleton Market Revenue and Volume, by Structure, 2024-2034

11.1.1. Rigid Exoskeleton

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Soft Exoskeleton

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Exoskeleton Market, By End-use

12.1. Exoskeleton Market Revenue and Volume, by End-use, 2024-2034

12.1.1. Industry

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Military

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

12.1.3. Healthcare

12.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Exoskeleton Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by Structure (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by Structure (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

Chapter 14. Company Profiles

14.1. ActiveLink (Panasonic Corporation)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Cyberdyne, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. ReWalk Robotics

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. RB3D

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Rex Bionics Plc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Suit X

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Lockheed Martin Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Hocoma

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Ekso Bionics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Sarcos

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client